Found 4439 clinical trials
Chikungunya
The goal of this multi-center, randomized, double blind, placebo controlled study is to evaluate the safety and immunogenicity of PXVX0317 in healthy adult and adolescent subjects.
- 0 views
- 18 Apr, 2022
- 1 location
Respiratory Syncytial Virus (RSV)
The study will enroll up to 23000 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and …
- 0 views
- 14 Jan, 2022
- 1 location
Pain Associated with Osteoarthritis of the Knee Clinical Research Study
Our Doctors are enrolling volunteers ages 35 to 85 in a pain associated with osteoarthritis of the knee clinical research study testing a topical spray to see if it helps reduce the pain associated with osteoarthritis of the knee.
- 30 views
- 18 Apr, 2022
- 1 location
Hot Flash
NIGHT SWEATS? HOT FLASHES? FLUSHES?You may be suffering from vasomotor symptoms.Learn more about a clinical research study for women with vasomotor symptoms after menopause. Insurance is not needed to participate in this study.
- 4 views
- 07 Mar, 2022
- 1 location
Eosinophilic Esophagitis Research Study
The purpose of this study is to see if CC-93538 is safe and effective as a possible treatment for EoE. To do this, a comparison will be made between subjects who receive CC-93538 and subjects who receive a placebo (a ‘dummy treatment’ that looks like CC-93538 but contains no active …
- 0 views
- 14 Jan, 2022
- 1 location
Gout
The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia.
- 0 views
- 21 Mar, 2023
- 1 location
Type 2 Diabetes
We are seeking participants for a new clinical research study to evaluate the effectiveness of a ONCE WEEKLY administration of basal (long-acting) insulin investigational medication compared to DAILY administration of insulin glargine (long-acting) in Type 2 Diabetics.
- 0 views
- 23 Jan, 2023
- 1 location
Healthy Volunteers Age 18 to 55 Needed! Payment up to $4,400 #N-30300
Altasciences LA (located in Cypress, CA), is looking for healthy volunteers for an upcoming clinical study.
- 0 views
- 02 Feb, 2023
- 1 location
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.
- 143 views
- 23 Nov, 2020
- 1 location
A 52-week study comparing the efficacy and safety of once weekly IcoSema and once weekly insulin Icodec, both treatment arms with or without oral anti-diabetic drugs, in participants with type 2 diabetes inadequately controlled with daily basal insulin. COMBINE 1
Objective: To confirm superiority of once weekly IcoSema compared with once weekly insulin Icodec, both treatment arms with or without OADs, in terms of glycaemic control measured by change in HbA1c from baseline after 52 weeks in participants with T2D inadequately controlled with daily basal insulin.
- 0 views
- 29 Sep, 2022
- 1 location